Study Shows Effectiveness of Merakris’ Wound Care Products
June 02, 2022 07:30 ET
|
Merakris Therapeutics
RESEARCH TRIANGLE PARK, N.C., June 02, 2022 (GLOBE NEWSWIRE) -- A peer-reviewed case study in the May 21 edition of SAGE Open Medical Case Reports highlights the effectiveness of two Merakris...
Merakris Announces Agreement With Miracles In Sight Eye Bank To Supply Opticyte® Repair Grafts to Eye Surgeons
July 20, 2021 06:30 ET
|
Merakris Therapeutics
RESEARCH TRIANGLE PARK, N.C., July 20, 2021 (GLOBE NEWSWIRE) -- Research Triangle Park-based biotechnology company Merakris Therapeutics has reached an agreement with Miracles In Sight (MIS) to...
BioStem Life Sciences, Inc., Subsidiary of BioStem Technologies, Inc., Announces Entry into Market with Four Amniotic Products
October 01, 2018 10:45 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, Oct. 01, 2018 (GLOBE NEWSWIRE) -- BioStem Life Sciences (“Life Sciences” or the “Company”), a wholly owned subsidiary of BioStem Technologies, Inc. (OTC PINK: BSEM), a...
AmnioLife to Participate at First Annual Interventional Orthopedic Foundation Conference October 23rd & 24th
October 06, 2015 05:00 ET
|
AmnioLife Corporation
GAINESVILLE, Fla., Oct. 06, 2015 (GLOBE NEWSWIRE) -- AmnioLife Corporation, a human cells, tissues, and cellular and tissue-based products developer, today announced that its CEO and Lead Scientist...
FL-Based Biotech, AmnioLife Corp. Closes $833K in Series A
June 03, 2015 06:30 ET
|
AmnioLife Corporation
GAINESVILLE, Fla., June 03, 2015 (GLOBE NEWSWIRE) -- AmnioLife Corporation, a human cells, tissues, and cellular and tissue-based products developer, today announced it has raised $833K in a Series...